It remains to be studied whether decreased transcellular transport capacities through blockade of VEGF‐A or VEGFR2 will be able to reduce the contacts of circulating IgG antibodies to follicular cells in Graves' disease. The gene discussed is VEGFA; the disease is Graves disease.